In our hands, Ole, in presence of liver steatosis, was able to further increase the expression levels of CTR1 and ATP7B, let thinking that a higher Cu-dependent antioxidant activity may be induced by the treatment with the nutraceuticals compound (Figs. 3, 4). This evidence concerns the gene ATP7B and fatty liver disease.